Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.65B
sum of reported positions
Reported positions
543
Changes vs prior quarter
567
60 new · 52 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 344 measured positions in 8 quarters, the typical new or larger position finished −1.0 pts against the S&P 500 and 48% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 592K | $72.4M | 1.3% | |
| 109K | $62.8M | 1.1% | |
| 652K | $62.7M | 1.1% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $4.72B | $5.65B |
| Positions | 535 | 543 |
| Biggest line | — | Mercury Systems 1% |
| 848K |
| $62.4M |
| 1.1% |
| 565K | $55M | 1.0% |
| 690K | $48M | 0.8% |
| 659K | $47.7M | 0.8% |
| 1.58M | $47.2M | 0.8% |
| 611K | $46.4M | 0.8% |
| 1.63M | $45.7M | 0.8% |
| 149K | $44.2M | 0.8% |
| 545K | $42.7M | 0.8% |
| 112K | $42.4M | 0.7% |
| 426K | $41.5M | 0.7% |
| 172K | $40.1M | 0.7% |
| 357K | $40.1M | 0.7% |
| 234K | $37.6M | 0.7% |
| 540K | $37.6M | 0.7% |
| 227K | $37.3M | 0.7% |
| 601K | $36.8M | 0.7% |
| 230K | $35.7M | 0.6% |
| 345K | $34.4M | 0.6% |
| 660K | $34.4M | 0.6% |
| 670K | $34.3M | 0.6% |
| 479K | $33.4M | 0.6% |
Assurant (AIZ)
85K → 89K shares (+5%)
American Healthcare REIT (AHR)
374K → 458K shares (+23%)
Rhythm Pharmaceuticals (RYTM)
66K → 193K shares (+194%)
Performance Food Group (PFGC)
176K → 190K shares (+8%)
Life Time Group Holdings, Inc. (LTH)
453K → 508K shares (+12%)
ICU Medical (ICUI)
126K → 129K shares (+3%)
Lsi Industries (LYTS)
674K → 709K shares (+5%)
Reliance, Inc. (RS)
27K → 48K shares (+76%)
Nurix Therapeutics (NRIX)
561K → 725K shares (+29%)
Polaris (PII)
190K → 248K shares (+30%)
Reinsurance Group of America (RGA)
74K → 80K shares (+8%)
NRG Energy (NRG)
69K → 116K shares (+69%)
UMB Financial Corp. (UMBF)
49K → 111K shares (+126%)
Graham (GHM)
110K → 127K shares (+16%)
Meiragtx Holdings (MGTX)
858K → 1.11M shares (+29%)
ADMA Biologics, Inc. (ADMA)
411K → 1.76M shares (+327%)
ESAB (ESAB)
118K → 145K shares (+23%)
Newamsterdam Pharma Co N.V. (NAMS)
408K → 421K shares (+3%)
Insight Enterprises, Inc. (NSIT)
20K → 117K shares (+483%)
Agios Pharmaceuticals (AGIO)
275K → 373K shares (+36%)
SPX Technologies (SPXC)
52K → 56K shares (+7%)
Teledyne Technologies (TDY)
20K → 20K shares (+2%)
Neogen (NEOG)
1.45M → 1.47M shares (+2%)
Coastal Financial (CCB)
159K → 168K shares (+6%)
Americold Realty Trust (COLD)
684K → 818K shares (+20%)